Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

Immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) therapy may vary substantially in their clinical presentation, including natural history, outcomes to treatment, and patterns. The application of clinical guidelines for irAE management can be challenging for pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Jarushka, Murphy, Catherine, Atkins, Michael B, Brahmer, Julie R, Champiat, Stephane, Feltquate, David, Krug, Lee M, Moslehi, Javid, Pietanza, M Catherine, Riemer, Joanne, Robert, Caroline, Sharon, Elad, Suarez-Almazor, Maria E, Suresh, Karthik, Turner, Michelle, Weber, Jeffrey, Cappelli, Laura C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069596/
https://www.ncbi.nlm.nih.gov/pubmed/37001909
http://dx.doi.org/10.1136/jitc-2022-006398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069596/
https://www.ncbi.nlm.nih.gov/pubmed/37001909
http://dx.doi.org/10.1136/jitc-2022-006398

Ejemplares similares